The Effectiveness of Self-Management Education and Telephone Follow-up in Patient with COPD Exacerbation

Last updated: November 25, 2024
Sponsor: Kirsehir Ahi Evran Universitesi
Overall Status: Active - Recruiting

Phase

N/A

Condition

Copd (Chronic Obstructive Pulmonary Disease)

Treatment

Telephone Follow-up

Self Management Education

Clinical Study ID

NCT06707649
2024/03/43
  • Ages > 18
  • All Genders

Study Summary

According to the 2024 GOLD guidelines, Chronic Obstructive Pulmonary Disease (COPD) is defined as heterogeneous lung condition characterized by chronic respiratory symptoms (dyspnea, cough, sputum production, and/or exacerbations) due to abnormalities of the airways (bronchitis, bronchiolitis) and/or alveoli (emphysema) that cause persistent, often progressive, airflow obstruction. COPD is one of the leading causes of mortality and morbidity in Turkey and worldwide. Since COPD is an incurable and lifelong disease, it is important for patients to have high levels of self-management.

The main questions it aims to answer are:

  1. Does self-management education and telephone follow-up intervention effect self-care agency and symptom management in people with COPD exacerbation?

  2. Does self-management education effect self-care agency and symptom management in people with COPD exacerbation? This study will evaluate the effect of self-management education and telephone follow-up on self-care agency and symptom management. Patients hospitalized with COPD exacerbation will be trained in the hospital and will be followed up by phone call after discharge. During the study, 3 groups were planned; Group 1 will be educated and followed up by telephone Group 2 will only receive education and no telephone follow-up. Group 3 will not receive education and telephone follow-up, only standard care. It is planned to collect the data from the patients at the beginning of the study, at 1, 3 and 6 months.

Main outcomes:

  • Level of self-care agency

  • Level of symptom management The results obtained will be interpreted by comparing between 3 groups.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Diagnosed with COPD for the last 1 year

  • Diagnosis of Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage IIIor IV COPD documented by pulmonary function testing

  • Patients hospitalized for acute exacerbation of COPD;

  • Hospitalized for at least 3 days

  • Having a personal mobile phone and the ability to use it,

  • Being enough conscious and oriented to answer the questions,

  • Voluntary patients

Exclusion

Exclusion Criteria:

  • Under 18 years old

  • Withdrawal from the study at any phase

  • Inability to be contacted by phone/mobile phone,

  • Patient death

Study Design

Total Participants: 150
Treatment Group(s): 2
Primary Treatment: Telephone Follow-up
Phase:
Study Start date:
September 01, 2024
Estimated Completion Date:
October 01, 2025

Connect with a study center

  • Kirsehir Training and Research Hospital

    Kirsehir, 40200
    Turkey

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.